Clorox (CLX) Tops Q3 EPS by 22c, FY EPS Guidance Tops Consensus
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Clorox Reports Q3 Fiscal Year 2020 Results, Updates Fiscal Year Outlook
May 1, 2020 6:30 AM EDTOAKLAND, Calif., May 1, 2020 /PRNewswire/ -- The Clorox Company (NYSE: CLX) reported sales growth of 15% and an increase in diluted net earnings per share (diluted EPS) of 31% for its third quarter of fiscal year 2020, which ended March 31, 2020. The company delivered sales and earnings growth in all reportable segments. Â
"Our hearts go out to everyone who has been affected by the COVID-19 pandemic. We're privileged to be in a position to serve the public health during this time," said Chair and CEO Benno Dorer. "Our commitment to doing everything we can to support consumers, healthcare... More
